Influence of food consumption patterns and Galician lifestyle on human gut microbiota
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Spain
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Diet Dietary,Diets,Diet,diet
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- low Southern European Atlantic Diet
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- high Southern European Atlantic Diet
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).
- Group 0 sample size Number of subjects in the control (unexposed) group
- 3
- Group 1 sample size Number of subjects in the case (exposed) group
- 7
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 6 months
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- RT-qPCR
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- ANOVA
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Signature 1
Source: Table 5
Description: Bacterial groups quantified in human fecal samples in subjects with low, intermediate, and high adherence to Southern European Atlantic Diet (SEAD)
Abundance in Group 1: increased abundance in high Southern European Atlantic Diet
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium |
Revision editor(s): WikiWorks
Experiment 2
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- intermediate Southern European Atlantic Diet
- Group 1 sample size Number of subjects in the case (exposed) group
- 21
Lab analysis
Statistical Analysis
Signature 1
Source: Table 5
Description: Bacterial groups quantified in human fecal samples in subjects with low, intermediate, and high adherence to Southern European Atlantic Diet (SEAD)
Abundance in Group 1: increased abundance in intermediate Southern European Atlantic Diet
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium |
Revision editor(s): WikiWorks
Experiment 3
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- <20 years participants
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- > 30 years participants
- Group 0 sample size Number of subjects in the control (unexposed) group
- 5
- Group 1 sample size Number of subjects in the case (exposed) group
- 11
Lab analysis
Statistical Analysis
Signature 1
Source: Table 4
Description: Gut microbiota composition in subjects of different age
Abundance in Group 1: increased abundance in > 30 years participants
NCBI | Quality Control | Links |
---|---|---|
Pseudomonadota |
Revision editor(s): WikiWorks
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- >20 years participants
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- 20-30 years participants
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
Lab analysis
Statistical Analysis
Signature 1
Source: Table 4
Description: Gut microbiota composition in subjects of different age
Abundance in Group 1: increased abundance in 20-30 years participants
NCBI | Quality Control | Links |
---|---|---|
Pseudomonadota |
Revision editor(s): WikiWorks
Experiment 5
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- 20-30 years participants
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- > 30 years participants
- Group 0 sample size Number of subjects in the control (unexposed) group
- 15
- Group 1 sample size Number of subjects in the case (exposed) group
- 11
Lab analysis
Statistical Analysis
Signature 1
Source: Table 4
Description: Gut microbiota composition in subjects of different age
Abundance in Group 1: increased abundance in > 30 years participants
NCBI | Quality Control | Links |
---|---|---|
Lactobacillus |
Revision editor(s): WikiWorks
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- BMI < 20
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMI >25
- Group 0 sample size Number of subjects in the control (unexposed) group
- 5
Lab analysis
Statistical Analysis
Signature 1
Source: Table 3
Description: Bacterial groups quantified in human fecal samples in subjects with different body mass index (BMI)
Abundance in Group 1: increased abundance in BMI >25
NCBI | Quality Control | Links |
---|---|---|
Actinomycetota | ||
Bacteroidota |
Revision editor(s): WikiWorks
Signature 2
Source: Table 3
Description: Bacterial groups quantified in human fecal samples in subjects with different body mass index (BMI)
Abundance in Group 1: decreased abundance in BMI >25
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium |
Revision editor(s): WikiWorks
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- BMI <20
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMI 20-25
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
Lab analysis
Statistical Analysis
Signature 1
Source: Table 3
Description: Bacterial groups quantified in human fecal samples in subjects with different body mass index (BMI)
Abundance in Group 1: decreased abundance in BMI 20-25
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium |
Revision editor(s): WikiWorks
Experiment 8
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- BMI 20-25
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMI >25
- Group 0 sample size Number of subjects in the control (unexposed) group
- 15
- Group 1 sample size Number of subjects in the case (exposed) group
- 11
Lab analysis
Statistical Analysis
Signature 1
Source: Table 3
Description: Bacterial groups quantified in human fecal samples in subjects with different body mass index (BMI)
Abundance in Group 1: increased abundance in BMI >25
NCBI | Quality Control | Links |
---|---|---|
Actinomycetota |
Revision editor(s): WikiWorks